In the BioHarmony Drug Report Database

"Preview" Icon

Miglitol

Glyset (miglitol) is a small molecule pharmaceutical. Miglitol was first approved as Glyset on 1996-12-18. It is used to treat type 2 diabetes mellitus in the USA. The pharmaceutical is active against maltase-glucoamylase, intestinal and lysosomal alpha-glucosidase.

 

Trade Name

 

Glyset
 

Common Name

 

miglitol
 

ChEMBL ID

 

CHEMBL1561
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Image (chem structure or protein)

Miglitol structure rendering